![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 487/04 | |
A61K 31/519 | |||
A61P 35/00 |
(11) | Number of the document | 2396333 |
(13) | Kind of document | T |
(96) | European patent application number | 10703945.5 |
Date of filing the European patent application | 2010-02-08 | |
(97) | Date of publication of the European application | 2011-12-21 |
(45) | Date of publication and mention of the grant of the patent | 2013-07-03 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2010/050191 |
Date | 2010-02-08 |
(87) | Number | WO 2010/092371 |
Date | 2010-08-19 |
(30) | Number | Date | Country code |
151221 P | 2009-02-10 | US | |
187766 P | 2009-06-17 | US |
(72) |
BRADBURY, Robert, Hugh, GB
CARR, Gregory, Richard, GB
RABOW, Alfred, Arthur, GB
RAO KORUPOJU, Srinivasa, IN
TUMMA, Harikrishna, IN
|
(73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
(54) | TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES AND THEIR USES FOR PROSTATE CANCER |
TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES AND THEIR USES FOR PROSTATE CANCER |